Quarterly ResultNov 10, 2026, 04:12 PM
Lumexa Imaging Q3 Net Income $7.2M vs Loss $3.5M; Revenue $272M
AI Summary
Lumexa Imaging Holdings, Inc. reported its third quarter 2026 financial results, showing a significant improvement in net income and revenue growth. The company announced a net income of $7.2 million, a substantial turnaround from a net loss of $3.5 million in the prior year's quarter. Revenue increased by 5.0% to $272.0 million. Key operational highlights include strong growth in advanced outpatient volumes and an increase in the advanced procedure mix. The company also updated its full-year 2026 outlook, reiterating revenue guidance and raising its Adjusted EPS forecast.
Key Highlights
- Revenue increased 5.0% to $272.0 million in Q3 2026 compared to $258.9 million in Q3 2025.
- Net income turned positive at $7.2 million in Q3 2026, compared to a net loss of $3.5 million in Q3 2025.
- Adjusted EBITDA was $62.6 million in Q3 2026, up from $59.1 million in Q3 2025.
- GAAP EPS was $0.07 and Adjusted EPS was $0.26 for Q3 2026.
- Advanced outpatient volume growth was 7.9% consolidated and 8.1% system-wide.
- Company reiterated full-year 2026 consolidated revenue guidance of $1.045 billion to $1.097 billion.
- Full-year 2026 Adjusted EPS guidance raised to $0.86 - $0.90 from $0.71 - $0.77.
Price Impact
More from LMRI